• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JYHZ1800151 阿昔莫司胶囊 acipimox Capsule Chemical Drugs License Renew 2018-06-04 辉瑞投资有限公司 Pfizer Investment Co Ltd Certificate Issued 2018-10-15 view
JYHB0701215 阿昔莫司胶囊 acipimox Capsule Chemical Drugs Supplementary Application 2007-12-24 辉瑞投资有限公司 Pfizer Investment Co Ltd Certificate Issued 2008-06-05 view
JYHB2001897 阿昔替尼片 axitinib Tablet Chemical Drugs Supplementary Application 2020-09-29 辉瑞投资有限公司 Pfizer Investment Co Ltd Filed 2020-10-16 view
JYHB1501184 阿昔替尼片 axitinib Tablet Chemical Drugs Supplementary Application 2015-08-24 辉瑞投资有限公司 Pfizer Investment Co Ltd Certificate Issued 2016-07-29 view
JYHZ1900133 阿昔替尼片 axitinib Tablet Chemical Drugs License Renew 2019-05-29 辉瑞投资有限公司 Pfizer Investment Co Ltd Certificate Issued 2019-12-05 view
JXHS1400081 阿昔替尼片 axitinib Tablet Chemical Drugs Import Drug Application 2014-08-15 辉瑞投资有限公司 Pfizer Investment Co Ltd Certificate Issued 2015-05-12 view
JYHB1601750 阿昔替尼片 axitinib Tablet Chemical Drugs Supplementary Application 2017-01-06 辉瑞投资有限公司 Pfizer Investment Co Ltd Certificate Issued 2017-06-07 view
JYHB2001530 阿昔替尼片 axitinib Tablet Chemical Drugs Supplementary Application 2020-08-24 辉瑞投资有限公司 Pfizer Investment Co Ltd Certificate Issued 2020-11-12 view
JXHL1200387 阿昔替尼片 axitinib Tablet Chemical Drugs Import Drug Application 2012-12-12 辉瑞投资有限公司 Pfizer Investment Co Ltd Certificate Issued 2014-08-11 view
JYHZ1900132 阿昔替尼片 axitinib Tablet Chemical Drugs License Renew 2019-05-29 辉瑞投资有限公司 Pfizer Investment Co Ltd Certificate Issued 2019-12-12 view
JXHS1400080 阿昔替尼片 axitinib Tablet Chemical Drugs Import Drug Application 2014-08-14 辉瑞投资有限公司 Pfizer Investment Co Ltd Certificate Issued 2015-05-12 view
JYHB1601752 阿昔替尼片 axitinib Tablet Chemical Drugs Supplementary Application 2017-01-06 辉瑞投资有限公司 Pfizer Investment Co Ltd Certificate Issued 2017-06-07 view
JYHB2000277 阿昔替尼片 axitinib Tablet Chemical Drugs Supplementary Application 2020-03-25 辉瑞投资有限公司 Pfizer Investment Co Ltd Certificate Issued 2020-05-11 view
JXHL1200388 阿昔替尼片 axitinib Tablet Chemical Drugs Import Drug Application 2012-12-06 辉瑞投资有限公司 Pfizer Investment Co Ltd Certificate Issued 2014-08-11 view
JYHB1901069 阿昔替尼片 axitinib Tablet Chemical Drugs Supplementary Application 2019-09-16 辉瑞投资有限公司 Pfizer Investment Co Ltd Certificate Issued 2019-11-06 view
JYHB2000276 阿昔替尼片 axitinib Tablet Chemical Drugs Supplementary Application 2020-03-25 辉瑞投资有限公司 Pfizer Investment Co Ltd Certificate Issued 2020-05-11 view
JYHB2001531 阿昔替尼片 axitinib Tablet Chemical Drugs Supplementary Application 2020-08-24 辉瑞投资有限公司 Pfizer Investment Co Ltd Certificate Issued 2020-11-12 view
JYHB2001898 阿昔替尼片 axitinib Tablet Chemical Drugs Supplementary Application 2020-09-29 辉瑞投资有限公司 Pfizer Investment Co Ltd Filed 2020-10-16 view
JYHB1501183 阿昔替尼片 axitinib Tablet Chemical Drugs Supplementary Application 2015-08-24 辉瑞投资有限公司 Pfizer Investment Co Ltd Certificate Issued 2016-07-29 view
JYHB1901070 阿昔替尼片 axitinib Tablet Chemical Drugs Supplementary Application 2019-09-11 辉瑞投资有限公司 Pfizer Investment Co Ltd Certificate Issued 2019-11-06 view